Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Curvebeam AI Ltd. ( (AU:CVB) ) has provided an announcement.
CurveBeam AI will release its quarterly Appendix 4C for the period ended 31 March 2026 before market open on 30 April, and is coupling the disclosure with an investor webinar hosted by its senior leadership team. The event, to be held at 9:30am AEST on the same day and later available as a recording, signals continued engagement with shareholders and the broader market as the company updates stakeholders on its financial and operational progress.
Investors and interested parties can register online to attend the webinar, submit questions live or in advance, and access a replay shortly after the session concludes. By structuring its quarterly results release around an interactive briefing, CurveBeam AI underscores its focus on transparency, potentially supporting investor confidence and liquidity in its ASX-listed shares as it pursues growth in the specialised medical imaging and AI diagnostics market.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited is a medical technology company that develops, manufactures and sells specialised point-of-care CT imaging equipment paired with AI-enabled SaaS clinical assessment tools for musculoskeletal care. Its flagship HiRise scanner performs both weight-bearing and traditional CT scans, and the company operates from a corporate base in Melbourne with global headquarters in Hatfield, Pennsylvania, employing more than 70 staff.
Average Trading Volume: 615,506
Technical Sentiment Signal: Sell
Current Market Cap: A$28.19M
Learn more about CVB stock on TipRanks’ Stock Analysis page.